Mendrisio, Switzerland

Elisabetta Donati

This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Sintetica S.a.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elisabetta Donati. Retrieved from https://idiyas.com/inventor/elisabetta-donati-nmlfa0b9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Elisabetta Donati: Innovator in Ophthalmic Formulations

Introduction

Elisabetta Donati is a prominent inventor based in Mendrisio, Switzerland. She has made significant contributions to the field of pharmaceutical formulations, particularly in ophthalmology. Her innovative work focuses on enhancing the safety and efficacy of topical anesthetics.

Latest Patents

Elisabetta holds a patent for "Topical formulations of chloroprocaine and methods of using same." This patent describes topical dosages and formulations of chloroprocaine and pharmaceutically acceptable salts that are efficacious, chemically stable, and physiologically balanced. These formulations are particularly beneficial during ophthalmic procedures or in response to ophthalmic abrasions or trauma.

Career Highlights

Elisabetta is associated with Sintetica S.A., a company known for its commitment to developing innovative pharmaceutical solutions. Her work has been instrumental in advancing the field of ophthalmic treatments, ensuring that patients receive safe and effective care.

Collaborations

Elisabetta collaborates with esteemed colleagues such as Augusto Mitidieri and Clara Bianchi. Their combined expertise contributes to the development of cutting-edge pharmaceutical products.

Conclusion

Elisabetta Donati's contributions to ophthalmic formulations exemplify her dedication to innovation in the pharmaceutical industry. Her work continues to impact patient care positively, showcasing the importance of research and development in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…